维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Decaux G"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Uric acid level in cirrhosis显示文摘	Decaux G	2000	J Clin Gastroen-terol2000，30，4：	1
2	Treatment of symptomatic hyponatremia显示文摘	Soupart A	2003	Am J Med Sci2003，326，：	1
3	Therapeutic recommendations for manage- ment of severe hyponatremia: current concepts on pathogenes is and prevention of neurologie complications 显示文摘	Soupart A Decaux G	1996	Clin Nephro1996，46，：	1
4	Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly 显示文摘	Muscb W Decaux G	2001	Int Urol Nephrol2001，32，3：	1
5	Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia显示文摘	Soupart A Ngassa M Decaux G	1999	Clin Nephrol1999，51，：	1
6	Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 reccptor antagonist VPA-985 显示文摘	Decaux G	2001	J Lab Clin Med2001，138，：	1
7	Non-peptide arginine-vasopressin antagonists:the vaptans显示文摘	Decaux G Soupart A Vassart G	2008	Lancet2008，371，9624：	1
8	Inappropriate secretion of ADH and central diabetes insipidus are related to antiphospholipid antibodies in SLE case report and review of the literature显示文摘	Kengne FG Decaux G	2006	Nephrol Dial Transplant2006，21，11：	1
9	Therapeutic recommendations for management of severe hyponatremia:current concepts on pathogenesis and prevention of neurologic complications显示文摘	Soupart A Decaux G	1996	Clin Nephrol1996，46，3：	1
10	Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia显示文摘	Annane D Decaux G Smith N	2009	Am J Med2009，337，1：	1
11	Inefficacy of intravenous immunoglobulins and infliximab in Degos' disease显示文摘	De Breucker S Vandergheynst F Decaux G	2008	Acta Clin Belg2008，63，2：	1
12	Therapentic relowering of the serum in a patient after excessive correction of hyponatremia显示文摘	Soupart A Ngassa M Decaux G	1999	Clin Nephrol1999，51，：	1
13	Long-term treatmenl of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan urea or furosemide显示文摘	Decaux G	2001	Am J Med2001，110，：	1
14	Evidence in hyponatremia related to inappropriate secretion of ADH that VⅥ receptor stimulation contributes to the increase in renal uric acid clearance显示文摘	Decaux G Namias B Gulbis B	1996	J Am Soc Nephrol1996，7，5：	1
15	Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial显示文摘	Alexander L. Gerbes Veit Gülberg Pere Ginès Guy Decaux Peter Gross Hassan Gandjini Jacques Djian	2003	Gastroenterology2003，，4：	1
16	Therapeutic recommendations for management of severe hyponatremia:current concepts on pathogenesis and prevention of neurologic complications显示文摘	Soupart A Decaux G	1996	Clin Nephrol1996，46，3：	1
17	Treatment of symptomatic hyponatremia显示文摘	Decaux G Soupart A	2003	Am J Med Sci2003，326，1：	1
18	Non-peptide arginine-vasopresin antagonists:the vaptans显示文摘	Decaux G Soupart A Vassart G	2008	Lancet2008，371，9624：	1
19	Non-peptide arginine-vasopressin antagonists:the vaptans显示文摘	Decaux G Soupart A Vassart G	2008	Lancet2008，371，9624：	1
20	MP infection associated with nerous system complications显示文摘	Decaux G Szyper M	1998	J Child Neurol1998，8，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示